Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the viability of extending BRCA testing to all women over 30 on request.
Answered by Steve Brine
NHS England currently commissions Medical Genetics Services to provide BRCA testing in accordance with a published clinical commissioning policy which is in line with current National Institute for Health and Care Excellence clinical guidelines. The test is available to women aged 30 and over. Further information is available at the following link:
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the viability of extending BRCA testing to all women over 30 on request.
Answered by Steve Brine
NHS England currently commissions Medical Genetics Services to provide BRCA testing in accordance with a published clinical commissioning policy which is in line with current National Institute for Health and Care Excellence clinical guidelines. The test is available to women aged 30 and over. Further information is available at the following link:
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Secretary of State for Education on the recommendations of the Royal College of Speech and Language Therapist report, Bercow: Ten Years, published on 20 March 2018.
Answered by Caroline Dinenage
Officials from the Department of Health and Social Care, and the Department for Education are in regular contact and work closely with national and local partners on policy to support children with speech, language and communication needs.
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will list the number of registered diabetics in each clinical commissioning group area.
Answered by Steve Brine
Information is not available in the format requested.
The number of patients aged 17 or over with diabetes mellitus, by clinical commissioning group in England for 2016-17 can be found in the attached table.
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what recent discussions he has had with East Midlands Ambulance Service on its response times to calls.
Answered by Philip Dunne
There have been no such discussions.
East Midlands Ambulance Service is participating in the Dispatch on Disposition pilot of NHS England’s Ambulance Response Programme (ARP). The ARP is part of NHS England’s Urgent and Emergency Care Review, which will transform ambulance services from a service based on a model of transportation to one of clinical assessment and treatment. We expect NHS England will make recommendations in Spring 2017.
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the timetable is for the publication of the findings of the Accelerated Access Review.
Answered by George Freeman
Sir Hugh Taylor published his interim report to the review on 27 October 2015. The review will conclude with Sir Hugh’s final recommendations to Government which are expected in spring 2016.
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps the Government is taking to support research into mesothelioma.
Answered by George Freeman
The Department's National Institute for Health Research (NIHR) and the Medical Research Council welcomes funding applications for research into any aspect of human health, including mesothelioma. These applications are subject to peer review and judged in open competition. These funders together spent over £3 million on mesothelioma research in 2014/15.
Following a themed call for mesothelioma research proposals, the NIHR has approved funding for two new projects (a total of about £0.5 million subject to contract) and a further two applications are currently under review.
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment his Department has made of the benefits of psychological support for (a) patients who have received and (b) the families of patients who have received a stem cell transplant.
Answered by Jane Ellison
The Government recognises the importance of supporting cancer survivors and is committed to working with the National Health Service, charities and patient groups to deliver the new Cancer Taskforce strategy.
The report of the independent Cancer Taskforce, Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020 (July 2015), states that we need to transform our approach to support people living with and beyond cancer. The strategy notes that depression in cancer patients can be treated by medication and by psychological treatment. These treatments are most effectively and efficiently delivered using a systematic collaborative care model, such as Depression Care for People with Cancer. Cancer Taskforce strategy recommends accelerating the roll-out of the Recovery Package that includes a needs assessment that may lead to a patient being referred to support services that include psychological support. The Cancer Taskforce report says that the aim should be that by 2020 every person with cancer will have access to elements of the Recovery Package.
We are working with the NHS, charities and patient groups to implement the independent Cancer Taskforce’s recommendations.
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much of the NHS budget (a) in cash terms and (b) as a proportion of the total budget has been spent on mental health services in each year since 2005.
Answered by Alistair Burt
The three tables below show the total National Health Service expenditure and total mental health expenditure. The reason the tables are split is due to NHS revenue expenditure and mental health expenditure not being directly comparable across the time period from 2004-05 to 2013-14.
The 2014-15 final outturn data is not yet available.
Table 1 shows years 2004-05 to 2007-08. The NHS expenditure figures are on a pre-Clear Line of Sight resource budgeting basis. The mental health expenditure is from Programme Budgeting data, information which is collected and published to help commissioners plan and spend their allocations.
Table 1
A | B | C | |
Financial Year | NHS Revenue Expenditure under pre Clear Line of Sight Rules (£ billion) | Mental Health Expenditure as per Programme Budgeting data (£ billion) | B as a % of A |
2004-05 | 66.87 | 7.22 | 10.80 |
2005-06 | 74.17 | 7.82 | 10.54 |
2006-07 | 78.47 | 8.41 | 10.72 |
2007-08 | 86.38 | 9.17 | 10.62 |
Table 2 shows years 2008-09 to 2012-13. NHS expenditure figures are on an aligned basis following the HM Treasury’s Clear Line of Sight programme. The mental health expenditure information is from Programme Budgeting data.
Table 2
A | B | C | |
Financial Year | NHS Revenue Expenditure under Clear Line of Sight Rules (£ billion) | Mental Health Expenditure as per Programme Budgeting data (£ billion) | B as a % of A |
2008-09 | 87.62 | 9.79 | 11.17 |
2009-10 | 94.42 | 10.61 | 11.24 |
2010-11 | 97.47 | 10.96 | 11.24 |
2011-12 | 100.27 | 11.16 | 11.13 |
2012-13 | 102.57 | 11.28 | 11.00 |
Table 3 shows 2013-14. The NHS expenditure figures are on an aligned basis following the HM Treasury’s Clear Line of Sight programme. The mental health expenditure for 2013-14 has been collected directly from NHS England.
Table 3
A | B | C | |
Financial Year | NHS Revenue Expenditure under Clear Line of Sight Rules (£ billion) | Mental Health Expenditure as per NHS England Accounts (£ billion) | B as a % of A |
2013-14 | 106.50 | 11.36 | 10.67 |
Unfortunately, it is not possible to directly compare each year due to the different reporting rules across the time period. One way to do this is to compare spending in real terms. The following table shows mental health expenditure since 2004-05 in 2013-14 prices -
Financial Year | Mental Health Expenditure in 2013-14 prices (£ billion) |
2004-05 | 8.95 |
2005-06 | 9.43 |
2006-07 | 9.87 |
2007-08 | 10.46 |
2008-09 | 10.89 |
2009-10 | 11.51 |
2010-11 | 11.57 |
2011-12 | 11.57 |
2012-13 | 11.51 |
2013-14 | 11.36 |
Asked by: Edward Argar (Conservative - Charnwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much his Department has provided for research into dementia (a) in cash terms, (b) in real terms, (c) as a proportion of the total research and development budget of his Department in each year since 2005.
Answered by George Freeman
Prior to the establishment of the National Institute for Health Research (NIHR) in April 2006, the main part of the Department’s total health research expenditure was devolved to and managed by National Health Service organisations. The NHS organisations reported on their use of these allocations in annual research and development (R&D) reports. These reports estimated total, aggregated spend on certain priority areas including dementia. Where a research project related to two or more priority areas, the expenditure on it was included within each relevant area. From April 2006 to March 2009, transitional research funding was allocated to these organisations at reducing levels. At the same time, an increasing amount of NHS research funding was awarded competitively through new NIHR programmes and schemes.
The following table shows estimated central R&D revenue budget spend on dementia through NHS R&D, the NIHR, and the Department’s Policy Research Programme (PRP), and this spend as a proportion of total expenditure from this budget.
| Estimated spend on dementia through NHS R&D, NIHR and PRP | |
|
£ million | Proportion of central R&D revenue budget % |
2005/06 | 18.3 | 2.8 |
2006/07 | 22.8 | 3.3 |
2007/08 | 22.2 | 2.9 |
2008/09 | 18.4 | 2.2 |
The following table shows estimated central R&D revenue budget spend on dementia through the NIHR, and the PRP, and this spend as a proportion of total expenditure from this budget.
| Estimated spend on dementia through NIHR and PRP | |
|
£ million | Proportion of central R&D revenue budget % |
2009/10 | 12.7 | 1.4 |
2010/11 | 18.6 | 1.9 |
2011/12 | 19.7 | 2.1 |
2012/13 | 25.6 | 2.6 |
2013/14 | 27.2 | 2.7 |
In 2011/12 there was also £5.4 million NIHR capital expenditure on dementia. Data for 2014/15 is not yet available.